Clinical Trial Update: Fisetin in Mild Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating fisetin for mild Alzheimer's disease is currently recruiting at Sunnybrook Health Sciences Centre.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Fisetin (fisetin)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Alzheimer s Disease, Alzheimer Dementia | Phase 2 | Status: RECRUITING